STENTiT
PrivateLast Round
Series A
Jun 25, 2025
Total Funding Raised
$4.67M
Company Overview
STENTiT operates in Healthcare & Life Sciences and is based in Eindhoven. Its latest recorded funding round was a Grant round in July 2023.
STENTiT is a medical device company developing regenerative endovascular implants that trigger a natural healing response to restore arteries from the inside-out.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
STENTiT Comparables
Compare STENTiT with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| R3 Vascular Inc. | 86% | |
| Micro Medical Solutions | 85% | |
| Zorion Medical | 85% |
For institutional investors. Book with your work email.
STENTiT Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 25, 2025 | ||||
| Grant | Jul 4, 2023 | ||||
| Seed | Apr 25, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
STENTiT Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Series A |
| Brabantse Ontwikkelings Maatschappij | Seed |
| Nextgen Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 209% MoM, reaching 1.5K.
- Nov 24, 2025
Named a finalist for the MedTech Innovator 2025 Mid-Stage Grand Prize.
For institutional investors. Book with your work email.
STENTiT Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about STENTiT's valuation, stock price, and market status.
Is STENTiT a public or private company?
STENTiT is a private company.
What is the current stock price of STENTiT?
STENTiT is a private company, so its shares have no public market price. Caplight tracks STENTiT's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is STENTiT worth (valuation)?
Valuation information for STENTiT is not publicly available.
Can I buy STENTiT stock?
STENTiT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was STENTiT's last funding round?
STENTiT's most recent funding round was Series A on June 25, 2025.
Who are the main investors in STENTiT?
Key investors in STENTiT include European Innovation Council Fund, Brabantse Ontwikkelings Maatschappij, Nextgen Ventures.
Will STENTiT IPO soon?
No public IPO plans have been announced for STENTiT.
How can I track STENTiT secondary market activity?
Caplight tracks bids, offers, and trades in STENTiT's shares on secondary markets.